NORTHVALE, N.J., Oct. 11, 2017 /PRNewswire/ -- ADM Tronics Unlimited, Inc. (OTCQB - ADMT) has just been selected by NJBIZ, New Jersey's leading business journal, as one of the 2017 Fast 50 Award Winners. The 50 Fastest Growing Companies awards program honors New Jersey's most dynamic businesses who progressively contribute to the success of the state's economic growth and stability.
"We are very pleased that NJBIZ has selected ADM Tronics for this recognition based on our recent record growth," stated Andre' DiMino, President and CEO of ADMT. "Although we are proud of our record numbers, we are equally excited to anticipate what levels our future growth may reach with the addition of revenues we hope to achieve from our new suite of proprietary medical device technologies planned to be introduced over the coming year."
As previously announced, ADMT is close to the launch of a hearing protection product, Tinnitus Shield™, which will help protect from excessive noise that can lead to tinnitus, a hearing condition where there is constant ringing in the ears. In addition, ADMT is redesigning its non-invasive tinnitus treatment device, the Aurex-3®, which is intended for use for the treatment and control of tinnitus by those already suffering from this debilitating condition.
Also, as recently announced, ADMT is nearing completion of development of the Alvio™ device, a respiratory therapy and training platform targeted for use in non-regulated respiratory training applications as well as for medical respiratory indications such as COPD (chronic obstructive pulmonary disease), CHF (congestive heart failure), and asthma.
"Our team of engineers is working diligently to prepare our current suite of medical devices for the market. In addition to Aurex-3® and Alvio™, we look forward to bringing additional innovative medical device technologies to fruition in the near future," stated ADMT Chief Science Officer Matthew Drummer.
New Jersey's Fast 50 is an awards program of NJBIZ, celebrating the dynamic growth of New Jersey companies. The rankings of the top 50 companies will be revealed during an awards ceremony to be held on November 14, 2017 in Somerset, NJ.
NJBIZ, New Jersey's leading business journal, produces a weekly print edition with a circulation of more than 15,000 copies, as well as providing 24/7 business news coverage through its NJBIZ.com website and multiple daily e-newsletters. The publication, founded in 1987 is well-known throughout the state for its events honoring New Jersey's top business professionals. It is owned by Bridge Tower Media, a leading provider of business-to-business information, research and marketing solutions across more than 20 local economies in the USA.
ADMT is a diversified, technology-based developer and manufacturer of innovative technologies and products. Its core competency is its ability to conceptualize a technology, bring it through development, into manufacturing and commercialization, all in-house. ADMT has three areas of activity: Proprietary Medical Devices; Medical Device Design, Engineering, Regulatory and Manufacturing Services; and Eco-Friendly, Water-Based Formulations. The Company's headquarters, laboratories, FDA-Registered medical device and manufacturing operations are in Northvale, NJ. ADMT's multi-disciplinary team of engineers, researchers and technologists utilize advanced technology infrastructure, such as 3-D prototyping, precision instrumentation and specialized software and peripherals, for research, development and commercialization of diversified technologies. Additional information is available at the Company's websites - admtronics.com and concepttoquantity.com.
Except for historical information contained herein, the matters set forth in this news release are "forward looking" statements (as defined in the Private Securities Litigation Reform Act of 1995), including statements regarding future revenue growth and performance. Although ADMT believes the expectations reflected in such forward looking statements are based upon reasonable assumptions, there can be no assurance that its expectations will be realized. Forward looking statements involve risks and uncertainties that could cause actual results to differ materially from expectations. Factors that could contribute to such differences include those described from time to time in ADMT's SEC filings, news releases and other communications. The Company assumes no obligation to update information contained in this news release.